Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 423

1.

Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.

Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP.

Clin Cancer Res. 2002 Jan;8(1):131-7.

2.

Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.

Fendri A, Masmoudi A, Khabir A, Sellami-Boudawara T, Daoud J, Frikha M, Ghorbel A, Gargouri A, Mokdad-Gargouri R.

Cancer Biol Ther. 2009 Mar;8(5):444-51. Epub 2009 Mar 21.

PMID:
19221469
3.

CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer.

Gutiérrez MI, Siraj AK, Khaled H, Koon N, El-Rifai W, Bhatia K.

Mod Pathol. 2004 Oct;17(10):1268-74.

4.

Aberrant promoter methylation of multiple genes in non-small cell lung cancers.

Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD.

Cancer Res. 2001 Jan 1;61(1):249-55.

5.

DNA hypermethylation status of multiple genes in soft tissue sarcomas.

Kawaguchi K, Oda Y, Saito T, Yamamoto H, Takahira T, Kobayashi C, Tamiya S, Tateishi N, Iwamoto Y, Tsuneyoshi M.

Mod Pathol. 2006 Jan;19(1):106-14.

6.

Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.

Lee TL, Leung WK, Chan MW, Ng EK, Tong JH, Lo KW, Chung SC, Sung JJ, To KF.

Clin Cancer Res. 2002 Jun;8(6):1761-6.

7.

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.

Cancer Res. 2002 Apr 15;62(8):2370-7.

8.
9.

Promoter hypermethylation profile of ovarian epithelial neoplasms.

Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.

Clin Cancer Res. 2005 Aug 1;11(15):5365-9.

10.

Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.

Choy KW, Pang CP, To KF, Yu CB, Ng JS, Lam DS.

Invest Ophthalmol Vis Sci. 2002 May;43(5):1344-9.

PMID:
11980845
11.

Aberrant promoter hypermethylation in serum DNA from patients with silicosis.

Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M.

Carcinogenesis. 2008 Sep;29(9):1845-9. doi: 10.1093/carcin/bgn169. Epub 2008 Jul 16.

12.

Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.

Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D, Thiagalingam S.

Clin Cancer Res. 2005 Apr 1;11(7):2466-70.

13.

CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients.

Gonzalez-Gomez P, Bello MJ, Arjona D, Alonso ME, Lomas J, Amiñoso C, de Campos JM, Sarasa JL, Gutierrez M, Rey JA.

Cancer Genet Cytogenet. 2003 Apr 1;142(1):21-4.

PMID:
12660028
14.

High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.

Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP.

Cancer Res. 2001 May 15;61(10):3877-81.

16.

Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients.

Tozawa T, Tamura G, Honda T, Nawata S, Kimura W, Makino N, Kawata S, Sugai T, Suto T, Motoyama T.

Cancer Sci. 2004 Sep;95(9):736-40.

17.

Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.

Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, Jen J, Sidransky D.

Cancer Res. 2001 Feb 1;61(3):939-42.

18.

Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.

Rossi D, Capello D, Gloghini A, Franceschetti S, Paulli M, Bhatia K, Saglio G, Vitolo U, Pileri SA, Esteller M, Carbone A, Gaidano G.

Haematologica. 2004 Feb;89(2):154-64.

19.

High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.

Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.

Mol Carcinog. 2002 Oct;35(2):85-92.

PMID:
12325038
20.
Items per page

Supplemental Content

Write to the Help Desk